|
- How DUPIXENT® (dupilumab) is Taken: Eczema Dosing
DUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies
- DUPIXENT® (dupilumab) for Moderate-to-Severe Eczema that is Uncontrolled
DUPIXENT® (dupilumab) is a subcutaneous injectable prescription medicine for uncontrolled moderate-to-severe eczema (atopic dermatitis) in adults children aged 6 months older Serious side effects can occur Please see Important Safety Information and Patient Information on website
- HIGHLIGHTS OF PRESCRIBING INFORMATION Dosage in Pediatric . . . - DUPIXENT
1 1 Atopic Dermatitis DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe atopic dermatitis whose disease is not adequately con-trolled with topical prescription therapies or when those therapies are not advisable DUPIXENT can be used with or without topical corticosteroids 1
- ENROLLMENT FORM Moderate-to-Severe Atopic Dermatitis - DUPIXENT
C M ET DUPIXENT MYWAY ENROLLMENT FORM Moderate-to-Severe Atopic Dermatitis SUBMIT COMPLETED PAGES 1 2 Fax: 1-844-387-9370 Document Drop: www patientsupportnow org (code: 8443879370)
- STAY AHEAD OF ECZEMA WITH DUPIXENT
DUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies DUPIXENT can be used with or without topical corticosteroids
- ICD-10-CM quick reference coding guide - DUPIXENT
Atopic Dermatitis: DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable DUPIXENT can be used with or without topical corticosteroids
- DUPIXENT IS APPROVED FOR 2 DERMATOLOGIC INDICATIONS THAT ARE DRIVEN IN . . .
pediatric patients through Week 16 was similar to that of adults with atopic dermatitis In an open-label extension study, the long-term safety profile of DUPIXENT ± TCS in pediatric patients observed through Week 52 was consistent with that seen in adults with atopic dermatitis, with hand-foot-and-mouth disease and skin papilloma
- Sample medical exception letter for DUPIXENT (dupilumab)
Atopic Dermatitis: DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable DUPIXENT can be used with or without topical corticosteroids
|
|
|